Serotonin and poor neonatal adaptation after antidepressant exposure in utero

Noera Kieviet, Vera Van Keulen, Peter Marinus Van De Ven, Koert Melchior Dolman, Martine Deckers, Adriaan Honig

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective Infants exposed to selective antidepressants (SADs) in utero are at risk to develop poor neonatal adaptation (PNA) postpartum. As symptoms are non-specific and the aetiology of PNA is unknown, the diagnostic process is hampered. We hypothesised that the serotonin metabolism plays a role in the aetiology of PNA. Methods In this controlled study, infants admitted postpartum from February 2012 to August 2013 were included and followed for 3 days. Infants exposed to SADs during at least the last 2 weeks of fetal life were included in the patient group (n=63). Infants not exposed to psychotropic medication and admitted postpartum for another reason were included in the control group (n=126). The neonatal urinary 5-hydroxyindoleacetid acid (5-HIAA) levels of SAD-exposed infants who developed PNA, SAD-exposed infants who did not develop PNA and control infants were compared. Results The course of the 5-HIAA levels over the first 3 days postpartum differed between infants with and without PNA (p≤0.001) with higher 5-HIAA levels in infants with PNA on day 1 (2.42 mmol/mol, p=0.001). Presence of maternal psychological distress modified this relationship. Conclusions A transient disturbance of the neonatal serotonergic system may play a role in the aetiology of PNA. Other factors, including the presence of maternal psychological distress, also seem to play a role.

Original languageEnglish
Pages (from-to)43-53
Number of pages11
JournalActa Neuropsychiatrica
Volume29
Issue number1
DOIs
Publication statusPublished - 1 Feb 2017

Cite this

Kieviet, Noera ; Van Keulen, Vera ; Van De Ven, Peter Marinus ; Dolman, Koert Melchior ; Deckers, Martine ; Honig, Adriaan. / Serotonin and poor neonatal adaptation after antidepressant exposure in utero. In: Acta Neuropsychiatrica. 2017 ; Vol. 29, No. 1. pp. 43-53.
@article{647567b3b0ed44b5899be72a6d25a329,
title = "Serotonin and poor neonatal adaptation after antidepressant exposure in utero",
abstract = "Objective Infants exposed to selective antidepressants (SADs) in utero are at risk to develop poor neonatal adaptation (PNA) postpartum. As symptoms are non-specific and the aetiology of PNA is unknown, the diagnostic process is hampered. We hypothesised that the serotonin metabolism plays a role in the aetiology of PNA. Methods In this controlled study, infants admitted postpartum from February 2012 to August 2013 were included and followed for 3 days. Infants exposed to SADs during at least the last 2 weeks of fetal life were included in the patient group (n=63). Infants not exposed to psychotropic medication and admitted postpartum for another reason were included in the control group (n=126). The neonatal urinary 5-hydroxyindoleacetid acid (5-HIAA) levels of SAD-exposed infants who developed PNA, SAD-exposed infants who did not develop PNA and control infants were compared. Results The course of the 5-HIAA levels over the first 3 days postpartum differed between infants with and without PNA (p≤0.001) with higher 5-HIAA levels in infants with PNA on day 1 (2.42 mmol/mol, p=0.001). Presence of maternal psychological distress modified this relationship. Conclusions A transient disturbance of the neonatal serotonergic system may play a role in the aetiology of PNA. Other factors, including the presence of maternal psychological distress, also seem to play a role.",
keywords = "central nervous system, depression, psychopharmacology, SSRI",
author = "Noera Kieviet and {Van Keulen}, Vera and {Van De Ven}, {Peter Marinus} and Dolman, {Koert Melchior} and Martine Deckers and Adriaan Honig",
year = "2017",
month = "2",
day = "1",
doi = "10.1017/neu.2016.30",
language = "English",
volume = "29",
pages = "43--53",
journal = "Acta Neuropsychiatrica",
issn = "0924-2708",
publisher = "Cambridge University Press",
number = "1",

}

Serotonin and poor neonatal adaptation after antidepressant exposure in utero. / Kieviet, Noera; Van Keulen, Vera; Van De Ven, Peter Marinus; Dolman, Koert Melchior; Deckers, Martine; Honig, Adriaan.

In: Acta Neuropsychiatrica, Vol. 29, No. 1, 01.02.2017, p. 43-53.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Serotonin and poor neonatal adaptation after antidepressant exposure in utero

AU - Kieviet, Noera

AU - Van Keulen, Vera

AU - Van De Ven, Peter Marinus

AU - Dolman, Koert Melchior

AU - Deckers, Martine

AU - Honig, Adriaan

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Objective Infants exposed to selective antidepressants (SADs) in utero are at risk to develop poor neonatal adaptation (PNA) postpartum. As symptoms are non-specific and the aetiology of PNA is unknown, the diagnostic process is hampered. We hypothesised that the serotonin metabolism plays a role in the aetiology of PNA. Methods In this controlled study, infants admitted postpartum from February 2012 to August 2013 were included and followed for 3 days. Infants exposed to SADs during at least the last 2 weeks of fetal life were included in the patient group (n=63). Infants not exposed to psychotropic medication and admitted postpartum for another reason were included in the control group (n=126). The neonatal urinary 5-hydroxyindoleacetid acid (5-HIAA) levels of SAD-exposed infants who developed PNA, SAD-exposed infants who did not develop PNA and control infants were compared. Results The course of the 5-HIAA levels over the first 3 days postpartum differed between infants with and without PNA (p≤0.001) with higher 5-HIAA levels in infants with PNA on day 1 (2.42 mmol/mol, p=0.001). Presence of maternal psychological distress modified this relationship. Conclusions A transient disturbance of the neonatal serotonergic system may play a role in the aetiology of PNA. Other factors, including the presence of maternal psychological distress, also seem to play a role.

AB - Objective Infants exposed to selective antidepressants (SADs) in utero are at risk to develop poor neonatal adaptation (PNA) postpartum. As symptoms are non-specific and the aetiology of PNA is unknown, the diagnostic process is hampered. We hypothesised that the serotonin metabolism plays a role in the aetiology of PNA. Methods In this controlled study, infants admitted postpartum from February 2012 to August 2013 were included and followed for 3 days. Infants exposed to SADs during at least the last 2 weeks of fetal life were included in the patient group (n=63). Infants not exposed to psychotropic medication and admitted postpartum for another reason were included in the control group (n=126). The neonatal urinary 5-hydroxyindoleacetid acid (5-HIAA) levels of SAD-exposed infants who developed PNA, SAD-exposed infants who did not develop PNA and control infants were compared. Results The course of the 5-HIAA levels over the first 3 days postpartum differed between infants with and without PNA (p≤0.001) with higher 5-HIAA levels in infants with PNA on day 1 (2.42 mmol/mol, p=0.001). Presence of maternal psychological distress modified this relationship. Conclusions A transient disturbance of the neonatal serotonergic system may play a role in the aetiology of PNA. Other factors, including the presence of maternal psychological distress, also seem to play a role.

KW - central nervous system

KW - depression

KW - psychopharmacology

KW - SSRI

UR - http://www.scopus.com/inward/record.url?scp=84978127416&partnerID=8YFLogxK

U2 - 10.1017/neu.2016.30

DO - 10.1017/neu.2016.30

M3 - Article

VL - 29

SP - 43

EP - 53

JO - Acta Neuropsychiatrica

JF - Acta Neuropsychiatrica

SN - 0924-2708

IS - 1

ER -